The prognostic value of KRAS mutation subtypes and PD-L1 expression in patients with lung adenocarcinoma.

e20022Background: KRAS gene mutations are found in 20-30% of non-small cell lung cancer (NSCLC), especially in adenocarcinoma. Compared to EGFR and ALK mutations, KRAS mutation in NSCLC may be asso...